|
|
Article: Lotronex Tablets now available for women with severe diarrhea-predominant IBS.(irritable bowel syndrome)
- Article from:
- Women's Health Weekly
- Article date:
- January 2, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 JAN 2 - (NewsRx.com & NewsRx.net) -- Lotronex (alosetron hydrochloride) Tablets will now be available under restricted conditions of use, which include a narrower indication for specific use in female patients with severe diarrhea-predominant irritable bowel syndrome (IBS), an extensive risk management program requiring participation of physicians, patients, and pharmacists, and several additional safety and efficacy studies.
"We're entering a new era for pharmaceuticals in the U.S.," said Peter Traber, MD, senior vice president and chief medical officer at GlaxoSmithKline. "The industry, the Food and Drug Administration (FDA), the medical profession, and ...